TechBio Founders #3: Treating mental illness: The Power of Psychedelics with Sam Banister, CSO Psylo

from Next Sequence · host Loretta TIOIELA

Psylo is a drug development company focused on next generation psychedelics; Their goal is to make broadly accessible medicines as improved treatments to currently available SSRI medications, using psychedelic molecules as the starting point. They are building a pipeline of novel molecules with the ultimate goal of taking leading candidates through to clinical trials.

NOW PLAYING

0:00 31:45

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Next Sequence?

This episode is 31 minutes long.

When was this Next Sequence episode published?

This episode was published on December 28, 2022.

What is this episode about?

Can I download this Next Sequence episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

URL copied to clipboard!